These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 19061217)

  • 1. Newborn screening for hemoglobinopathies in California.
    Michlitsch J; Azimi M; Hoppe C; Walters MC; Lubin B; Lorey F; Vichinsky E
    Pediatr Blood Cancer; 2009 Apr; 52(4):486-90. PubMed ID: 19061217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Newborn screening for hemoglobin disorders.
    Hoppe CC
    Hemoglobin; 2011; 35(5-6):556-64. PubMed ID: 21910601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asian immigration and public health in California: thalassemia in newborns in California.
    Lorey F
    J Pediatr Hematol Oncol; 2000; 22(6):564-6. PubMed ID: 11132231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Newborn screening for non-sickling hemoglobinopathies.
    Hoppe CC
    Hematology Am Soc Hematol Educ Program; 2009; ():19-25. PubMed ID: 20008178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Newborn screening program for hemoglobinopathies in Rio de Janeiro, Brazil.
    Lobo CL; Ballas SK; Domingos AC; Moura PG; do Nascimento EM; Cardoso GP; de Carvalho SM
    Pediatr Blood Cancer; 2014 Jan; 61(1):34-9. PubMed ID: 24038856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carrier screening for thalassemia and hemoglobinopathies in Canada.
    Langlois S; Ford JC; Chitayat D; ;
    J Obstet Gynaecol Can; 2008 Oct; 30(10):950-959. PubMed ID: 19038079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neonatal screening for sickle cell disease and other hemoglobinopathies in "the changing Europe".
    Rolla R; Castagno M; Zaffaroni M; Grigollo B; Colombo S; Piccotti S; Dellora C; Bona G; Bellomo G
    Clin Lab; 2014; 60(12):2089-93. PubMed ID: 25651745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Universal screening for hemoglobinopathies using high-performance liquid chromatography: clinical results of 2.2 million screens.
    Lorey F; Cunningham G; Shafer F; Lubin B; Vichinsky E
    Eur J Hum Genet; 1994; 2(4):262-71. PubMed ID: 7704556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of hemoglobinopathy variants by ethnicity in a multiethnic state.
    Lorey FW; Arnopp J; Cunningham GC
    Genet Epidemiol; 1996; 13(5):501-12. PubMed ID: 8905396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Newborn screening for sickle cell and other hemoglobinopathies: a Canadian pilot study.
    Yorke D; Mitchell J; Clow C; Nuguid E; Cadogan R; Sinclair D; Luscombe S; Rozen R; Meredith P; Esseltine D
    Clin Invest Med; 1992 Aug; 15(4):376-83. PubMed ID: 1516295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing prenatal and neonatal diagnosis of hemoglobinopathies.
    Schoen EJ; Marks SM; Clemons MM; Bachman RP
    Pediatrics; 1993 Sep; 92(3):354-7. PubMed ID: 8361789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neonatal screening for hemoglobinopathies: a one-year experience in the public health system in Rio Grande do Sul State, Brazil].
    Sommer CK; Goldbeck AS; Wagner SC; Castro SM
    Cad Saude Publica; 2006 Aug; 22(8):1709-14. PubMed ID: 16832542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Newborn screening for sickle cell disease: 4 years of experience from California's newborn screening program.
    Shafer FE; Lorey F; Cunningham GC; Klumpp C; Vichinsky E; Lubin B
    J Pediatr Hematol Oncol; 1996 Feb; 18(1):36-41. PubMed ID: 8556368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Universal newborn screening for haemoglobinopathies in Guadeloupe (French West Indies): a 27-year experience.
    Saint-Martin C; Romana M; Bibrac A; Brudey K; Tarer V; Divialle-Doumdo L; Petras M; Keclard-Christophe L; Lamothe S; Broquere C; Etienne-Julan M
    J Med Screen; 2013 Dec; 20(4):177-82. PubMed ID: 24144845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic utility of isoelectric focusing and high performance liquid chromatography in neonatal cord blood screening for thalassemia and non-sickling hemoglobinopathies.
    Uaprasert N; Settapiboon R; Amornsiriwat S; Sarnthammakul P; Thanapat T; Rojnuckarin P; Sutcharitchan P
    Clin Chim Acta; 2014 Jan; 427():23-6. PubMed ID: 24095765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution of thalassemias and associated hemoglobinopathies identified by prenatal diagnosis in Taiwan.
    Peng CT; Liu SC; Peng YC; Lin TH; Wang SJ; Le CY; Shih MC; Tien N; Lu JJ; Lin CY
    Blood Cells Mol Dis; 2013 Oct; 51(3):138-41. PubMed ID: 23689197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New Born Screening of Hemoglobinopathies in a Center Tunisian Population.
    Chaouch L; Moumni I; Ben Abdallah J; Bouchahda R; Methlouthi J; Mahdhaoui N; Matamri W; Braham N; Bouguila F; Mejri L; Charefeddine B; Chaieb A; Khairi H; Menif S
    J Pediatr Hematol Oncol; 2024 Jul; 46(5):e296-e299. PubMed ID: 38748601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Newborn Screening for Hemoglobinopathies and Red Cell Enzymopathies in Tripura State: A Malaria-Endemic State in Northeast India.
    Upadhye D; Das RS; Ray J; Acharjee S; Ghosh K; Colah RB; Mukherjee MB
    Hemoglobin; 2018 Jan; 42(1):43-46. PubMed ID: 29417859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pattern of hemoglobinopathies and thalassemias in upper Assam region of North Eastern India: high performance liquid chromatography studies in 9000 patients.
    Baruah MK; Saikia M; Baruah A
    Indian J Pathol Microbiol; 2014; 57(2):236-43. PubMed ID: 24943756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Forecasting hemoglobinopathy burden through neonatal screening in Omani neonates.
    Alkindi S; Al Zadjali S; Al Madhani A; Daar S; Al Haddabi H; Al Abri Q; Gravell D; Berbar T; Pravin S; Pathare A; Krishnamoorthy R
    Hemoglobin; 2010 Jan; 34(2):135-44. PubMed ID: 20353348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.